134 related articles for article (PubMed ID: 32930885)
21. A Novel PTCH1 Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome.
Durmaz CD; Evans G; Smith MJ; Ertop P; Akay BN; Tuncalı T
Cytogenet Genome Res; 2018; 154(2):57-61. PubMed ID: 29544218
[TBL] [Abstract][Full Text] [Related]
22. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.
Taylor MD; Zhang X; Liu L; Hui CC; Mainprize TG; Scherer SW; Wainwright B; Hogg D; Rutka JT
Oncogene; 2004 Jun; 23(26):4577-83. PubMed ID: 15077159
[TBL] [Abstract][Full Text] [Related]
23. Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature.
Siegfried A; Bertozzi AI; Bourdeaut F; Sevely A; Loukh N; Grison C; Miquel C; Lafon D; Sevenet N; Pietsch T; Dufour C; Delisle MB
Clin Neuropathol; 2016; 35(3):106-13. PubMed ID: 26857864
[TBL] [Abstract][Full Text] [Related]
24. SUFU-associated Gorlin syndrome: Expanding the spectrum between classic nevoid basal cell carcinoma syndrome and multiple hereditary infundibulocystic basal cell carcinoma.
Álvarez-Salafranca M; García-García M; Montes-Torres A; Rivera-Fuertes I; López-Giménez MT; Ara M
Australas J Dermatol; 2023 May; 64(2):249-254. PubMed ID: 36825822
[TBL] [Abstract][Full Text] [Related]
25. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.
Güran S; Tunca Y; Imirzalioğlu N
Cancer Genet Cytogenet; 1999 Sep; 113(2):145-51. PubMed ID: 10484981
[TBL] [Abstract][Full Text] [Related]
26. Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model.
Niesen J; Ohli J; Sedlacik J; Dührsen L; Hellwig M; Spohn M; Holsten T; Schüller U
Cancer Lett; 2020 May; 477():10-18. PubMed ID: 32112900
[TBL] [Abstract][Full Text] [Related]
27. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z
Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116
[TBL] [Abstract][Full Text] [Related]
28. Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastoma.
Bourdeaut F; Miquel C; Richer W; Grill J; Zerah M; Grison C; Pierron G; Amiel J; Krucker C; Radvanyi F; Brugieres L; Delattre O
Pediatr Blood Cancer; 2014 Feb; 61(2):383-6. PubMed ID: 24115570
[TBL] [Abstract][Full Text] [Related]
29. Evasion of cell senescence in SHH medulloblastoma.
Tamayo-Orrego L; Swikert SM; Charron F
Cell Cycle; 2016 Aug; 15(16):2102-2107. PubMed ID: 27229128
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional up-regulation of Gadd45a in Patched-associated medulloblastoma.
Kappler R; Hess I; Schlegel J; Hahn H
Int J Oncol; 2004 Jul; 25(1):113-20. PubMed ID: 15201996
[TBL] [Abstract][Full Text] [Related]
31. Gorlin syndrome-induced pluripotent stem cells form medulloblastoma with loss of heterozygosity in
Ikemoto Y; Miyashita T; Nasu M; Hatsuse H; Kajiwara K; Fujii K; Motojima T; Kokido I; Toyoda M; Umezawa A
Aging (Albany NY); 2020 May; 12(10):9935-9947. PubMed ID: 32436863
[TBL] [Abstract][Full Text] [Related]
32. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
[TBL] [Abstract][Full Text] [Related]
33. Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas.
Menyhárt O; Győrffy B
Ann Clin Transl Neurol; 2019 May; 6(5):990-1005. PubMed ID: 31139698
[TBL] [Abstract][Full Text] [Related]
34. Pediatric pituitary adenoma and medulloblastoma in the setting of p53 mutation: case report and review of the literature.
Birk H; Kandregula S; Cuevas-Ocampo A; Wang CJ; Kosty J; Notarianni C
Childs Nerv Syst; 2022 Sep; 38(9):1783-1789. PubMed ID: 35254474
[TBL] [Abstract][Full Text] [Related]
35. GLI3 is not mutated commonly in sporadic medulloblastomas.
Erez A; Ilan T; Amariglio N; Muler I; Brok-Simoni F; Rechavi G; Izraeli S
Cancer; 2002 Jul; 95(1):28-31. PubMed ID: 12115313
[TBL] [Abstract][Full Text] [Related]
36. SUFU: The Jekyll and Hyde of the Cerebellum.
Kim LJY; Bhargava S; Gimple RC; Rich JN
Dev Cell; 2019 Jan; 48(2):131-132. PubMed ID: 30695694
[TBL] [Abstract][Full Text] [Related]
37. Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas.
Surun A; Varlet P; Brugières L; Lacour B; Faure-Conter C; Leblond P; Bertozzi-Salomon AI; Berger C; André N; Sariban E; Raimbault S; Prieur F; Desseigne F; Zattara H; Guimbaud R; Polivka M; Delisle MB; Vasiljevic A; Maurage CA; Figarella-Branger D; Coulet F; Guerrini-Rousseau L; Alapetite C; Dufour C; Colas C; Doz F; Bourdeaut F
Neuro Oncol; 2020 Jan; 22(1):128-138. PubMed ID: 31504825
[TBL] [Abstract][Full Text] [Related]
38. Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma.
Azzollini J; Schiavello E; Buttarelli FR; Clerici CA; Tizzoni L; Vecchi G; Capra F; Pisati F; Biassoni V; Runza L; Carrabba G; Giangaspero F; Massimino M; Pensotti V; Manoukian S
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899294
[TBL] [Abstract][Full Text] [Related]
39. SHH inhibitors for the treatment of medulloblastoma.
Samkari A; White J; Packer R
Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
[TBL] [Abstract][Full Text] [Related]
40. Novel PTCH1 mutations in Japanese Nevoid basal cell carcinoma syndrome patients: two familial and three sporadic cases including the first Japanese patient with medulloblastoma.
Fujii M; Noguchi K; Urade M; Muraki Y; Moridera K; Kishimoto H; Hashimoto-Tamaoki T; Nakano Y
J Hum Genet; 2011 Apr; 56(4):277-83. PubMed ID: 21368767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
